Skip to content
All Podcasts – Lifestyle
Author:
MAHZI Therapeutics
Mahzi Therapeutics Announces First Patient Dosed in Phase 1/2 UNITE Study of MZ-1866 for Pitt Hopkins Syndrome
March 4, 2026